Zennea’s vision is to end sleepless nights by preventing chronic snoring and treating sleep related breathing conditions. They are developing the first medical device that will reduce snoring by externally reducing airway restriction through neuro-stimulation. ZENS is a wearable device that adheres under the chin and uses transcutaneous electrical nerve stimulation to reduce airflow restrictions. The device sends a bi-phasic waveform to each side of the midline that stimulations targeted nerves and subsequent muscle groups that control the upper airway. Zennea will seek market authorization from the FDA, so people who snore won’t have to ever worry about ineffective solutions.